Creo Medical Group (LON:CREO) Trading Down 1% - Should You Sell?

Key Points

• Creo Medical Group's stock price declined by 1%, closing at GBX 13 after trading as low as GBX 12.75.
• The company had a market capitalization of £53.62 million with a PE ratio of -162.50 and a notably high debt-to-equity ratio of 29.96.
• Insiders, including Craig Jonathan Gulliford and Richard John Rees, each sold 6,429 shares at an average price of GBX 14, totaling around £900.06 each.

Shares of Creo Medical Group PLC (LON:CREO - Get Free Report) fell 1% during mid-day trading on Thursday . The company traded as low as GBX 12.75 ($0.17) and last traded at GBX 13 ($0.18). 341,206 shares traded hands during mid-day trading, a decline of 68% from the average session volume of 1,075,623 shares. The stock had previously closed at GBX 13.13 ($0.18).

Creo Medical Group Stock Up 1.0%

The company has a debt-to-equity ratio of 29.96, a current ratio of 3.24 and a quick ratio of 2.19. The firm has a 50-day simple moving average of GBX 13.17 and a two-hundred day simple moving average of GBX 12.71. The company has a market cap of £52.57 million, a PE ratio of -159.31 and a beta of 0.86.

Insider Transactions at Creo Medical Group

In other Creo Medical Group news, insider Craig Jonathan Gulliford sold 6,429 shares of the firm's stock in a transaction dated Tuesday, July 22nd. The shares were sold at an average price of GBX 14, for a total transaction of £900.06. Also, insider Richard John Rees sold 6,429 shares of Creo Medical Group stock in a transaction dated Tuesday, July 22nd. The stock was sold at an average price of GBX 14, for a total transaction of £900.06. 4.10% of the stock is currently owned by corporate insiders.

Creo Medical Group Company Profile

Creo Medical is a medical device company focused on the development and commercialisation of minimally invasive electrosurgical devices, bringing advanced energy to endoscopy. The Company's vision is to improve patient outcomes through the development and commercialisation of a suite of electrosurgical medical devices, each enabled by CROMA, powered by Kamaptive.